NCT06650436

Brief Summary

Primary objective of this study: determine whether PSD is a risk factor for PSCI, independent of brain frailty and premorbid cognitive functioning. Secondary objectives:

  1. 1.to investigate the role of infarct location, imaging markers of brain frailty and brain network disintegration in the development of PSD;
  2. 2.to investigate the role of persistent brain network disintegration in the development of PSCI.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started May 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
May 2024May 2026

First Submitted

Initial submission to the registry

May 13, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

May 20, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

October 21, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Expected
Last Updated

October 21, 2024

Status Verified

October 1, 2024

Enrollment Period

1.9 years

First QC Date

May 13, 2024

Last Update Submit

October 17, 2024

Conditions

Keywords

Post stroke deliriumPost-stroke cognitive impairmentEEGDeliriumIschemic StrokeCognitive Impairment

Outcome Measures

Primary Outcomes (11)

  • Post-stroke delirium

    Firstly using the 4 A's test (4AT) to screen for delirium. This score can go from 0 which indicates no suspicion of delirium; to a score higher than 4 which does indicates a higher suspicion of delirium. Then we'll further analyse the type of delirium using the Richmond Agitation-Sedation Scale (RASS). This scale has 2 types of scores, the first one being the negative scores (-5 -\> -1) that fits a hypoactive presentation of delirium. 0 is a normal score, indicating an alert and calm patient. The positive scores (1 -\> 4) are administered in case of hyperactive presentations of delirium.

    first 72 hours after stroke symptom onset

  • The role of brain network disintegration in post-stroke delirium: electrical analysis of the relative power in the alfa frequency band

    To further understand the underlying brain activity during post-stroke delirium we'll perform an additional electroencephalogram (EEG) to look at potential deviations in the brain activity that could be connected to this clinical presentation. We'll specifically look at the relative power in the alfa frequency band.

    first 72 hours after stroke symptom onset

  • The role of brain network disintegration in post-stroke delirium: electrical analysis of the relative power in the beta frequency band

    To further understand the underlying brain activity during post-stroke delirium we'll perform an additional electroencephalogram (EEG) to look at potential deviations in the brain activity that could be connected to this clinical presentation. We'll specifically look at the relative power in the beta frequency band.

    first 72 hours after stroke symptom onset

  • The role of brain network disintegration in post-stroke delirium: electrical analysis of the relative power in the delta frequency band

    To further understand the underlying brain activity during post-stroke delirium we'll perform an additional electroencephalogram (EEG) to look at potential deviations in the brain activity that could be connected to this clinical presentation. We'll specifically look at the relative power in the delta frequency band.

    first 72 hours after stroke symptom onset

  • The role of brain network disintegration in post-stroke delirium: electrical analysis of the relative power in the theta frequency band

    To further understand the underlying brain activity during post-stroke delirium we'll perform an additional electroencephalogram (EEG) to look at potential deviations in the brain activity that could be connected to this clinical presentation. We'll specifically look at the relative power in the theta frequency band.

    first 72 hours after stroke symptom onset

  • The role of brain network disintegration in post-stroke delirium: electrical analysis of the relative power in the peak frequency band

    To further understand the underlying brain activity during post-stroke delirium we'll perform an additional electroencephalogram (EEG) to look at potential deviations in the brain activity that could be connected to this clinical presentation. We'll specifically look at the relative power in the peak frequency band.

    first 72 hours after stroke symptom onset

  • The role of brain network disintegration in post-stroke delirium: electrical analysis of the phase lag index (PLI)

    To further understand the underlying brain activity during post-stroke delirium we'll perform an additional electroencephalogram (EEG) to look at potential deviations in the brain activity that could be connected to this clinical presentation. We'll specifically look at the phase lag index (PLI) to assess functional connectivity between time series based on the consistency with which one signal is leading or lagging with respect to another signal. The PLI characterizes the assymetry in the distribution of instantaneous phase differences between signals.

    first 72 hours after stroke symptom onset

  • Post-stroke cognitive impairment

    Using the Montreal Cognitive Assessment (MOCA) score. This is a maximum score of 30 points where a normal cognition is linked to a score of 26 or higher.

    3 months and 12 months after stroke symptom onset

  • Post-stroke depression

    Using the Patient Health Questionnaire-2 (PHQ-2). These scores range from 0 to 6. A score of 3 or higher indicates that major depressive disorder is likely.

    3 months and 12 months after stroke symptom onset

  • Post-stroke depression

    Using the Hospital Anxiety and Depression Scale (HADS). This test has a maximum of 21 points. Between 8 and 10 there is a possibility that the patient suffers from anxiety or depression. Between 11 and 21 it is likely that the patient suffers from anxiety or depression.

    3 months and 12 months after stroke symptom onset

  • Markers of brain frailty

    * visual rating of white matter hyperintensities using the Fazekas scale. * Visual rating of cerebral atrophy using the global cortical atrophy scale.

    First 72 hours and 12 months after stroke symptom onset

Secondary Outcomes (3)

  • Key drivers of post-stroke delirium.

    12 months after stroke symptom onset

  • Role infarct location

    12 months after stroke symptom onset

  • Key drivers of post-stroke cognitive impairment.

    12 months after stroke symptom onset

Study Arms (2)

no delirium post-stroke

Diagnostic Test: EEGDiagnostic Test: MRIDiagnostic Test: Depression screening and neuropsychological tests

post-stroke delirium

Diagnostic Test: EEGDiagnostic Test: MRIDiagnostic Test: Depression screening and neuropsychological tests

Interventions

EEGDIAGNOSTIC_TEST

The phase lag index will be used to assess functional connectivity between time series based on the consistency with which one signal is leading or lagging with respect to another signal.The PLI characterizes the asymmetry in the distribution of instantaneous phase differences between signals. If such an asymmetry is present, a phase coupling is assumed between signals, reflecting synchronized activity. Importantly, zero-phase coupling is discarded in the PLI as this may represent activity from common sources picked up at different electrodes. Based on the MST, network measures can be calculated. It is a measure of network efficiency. Leaf fraction quantifies the fraction of nodes in the whole network that have only one connecting edge, which is a measure of network integration.

no delirium post-strokepost-stroke delirium
MRIDIAGNOSTIC_TEST

Manual segmentation of the acute ischemic lesion will be performed on MRI of the brain. Support vector regression-based lesion symptom mapping (SVR-LSM) will be performed to determine the association between AIL location and PSD. We will also perform an assumption-free region of interest (ROI)-based analysis by using support vector regression. The ROIs will be determined by the AAL atlas and ICBM-DTI-81 white matter tract atlas in MNI-152 space. The MRI's will be performed within 72 hours of the stroke onset with a follow-up of 12 months.

no delirium post-strokepost-stroke delirium

Screening post-stroke delirium (during first 72hours after stroke symptom onset): 4AT test score: 0-12 (\>/= 4: diagnosis of (post-stroke) delirium) RASS score: from -5 until +4 Screening post-stroke cognitive impairment (3months, 12 months): MOCA score: 0-30 Screening post-stroke depression: Patient Health Questionnaire-2: score 0-6 Hospital Anxiety and Depression Scale: score 0-21Anxiety and 0-21Depression

no delirium post-strokepost-stroke delirium

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients hospitalized at the stroke unit of UZ Brussel, who can be included within 72 hours after stroke symptom onset.

You may qualify if:

  • years or older,
  • admitted at stroke unit of UZ Brussel,
  • ability to participate in cognitive assessments,
  • fluency in Dutch or French,
  • ability to undergo an EEG during the first 24 hours after onset of stroke symptoms,
  • ability to undergo MRI of the brain.

You may not qualify if:

  • epilepsy history,
  • pre-existing, space occupying brain lesion (except small meningeoma),
  • pregnancy or wish to become pregnant,
  • severe language impairment or dementia impeding cognitive assessment, life expectancy of less than 1 year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitair Ziekenhuis Brussel

Brussels, 1090, Belgium

RECRUITING

MeSH Terms

Conditions

Ischemic StrokeDeliriumCognitive Dysfunction

Interventions

Electroencephalography

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesConfusionNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersCognition Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 13, 2024

First Posted

October 21, 2024

Study Start

May 20, 2024

Primary Completion

May 1, 2026

Study Completion (Estimated)

May 31, 2026

Last Updated

October 21, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations